143 related articles for article (PubMed ID: 11405830)
1. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
Smith MF; Doyle JW
Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
[TBL] [Abstract][Full Text] [Related]
2. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
[TBL] [Abstract][Full Text] [Related]
3. Treatment of failing glaucoma filtering cystic blebs with tissue plasminogen activator (tPA).
Lee PF; Myers KS; Hsieh MM; Wood EF; Hotaling DM
J Ocul Pharmacol Ther; 1995; 11(3):227-32. PubMed ID: 8590254
[TBL] [Abstract][Full Text] [Related]
4. Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.
Lundy DC; Sidoti P; Winarko T; Minckler D; Heuer DK
Ophthalmology; 1996 Feb; 103(2):274-82. PubMed ID: 8594514
[TBL] [Abstract][Full Text] [Related]
5. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
Wedrich A; Menapace R; Ries E; Polzer I
J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671
[TBL] [Abstract][Full Text] [Related]
6. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
Georgiadis N; Boboridis K; Halvatzis N; Ziakas N; Moschou V
J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
[TBL] [Abstract][Full Text] [Related]
7. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants.
Zalta AH; Sweeney CP; Zalta AK; Kaufman AH
Arch Ophthalmol; 2002 Nov; 120(11):1487-93. PubMed ID: 12427061
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of successful filtering blebs at 1 year after trabeculectomy using swept-source three-dimensional anterior segment optical coherence tomography.
Narita A; Morizane Y; Miyake T; Seguchi J; Baba T; Shiraga F
Jpn J Ophthalmol; 2017 May; 61(3):253-259. PubMed ID: 28197740
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye].
Rehfeldt K; Höh H
Ophthalmologe; 1999 Sep; 96(9):587-93. PubMed ID: 10501987
[TBL] [Abstract][Full Text] [Related]
10. The use of tissue plasminogen activator in experimental filtration surgery.
Ozment RR; Laiw ZC; Latina MA
Ophthalmic Surg; 1992 Jan; 23(1):22-30. PubMed ID: 1574262
[TBL] [Abstract][Full Text] [Related]
11. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
Dotan A; Kaiserman I; Kremer I; Ehrlich R; Bahar I
Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival Advancement With Subconjunctival Amniotic Membrane Draping Technique for Leaking Cystic Blebs.
Sethi P; Patel RN; Goldhardt R; Ayyala RS
J Glaucoma; 2016 Feb; 25(2):188-92. PubMed ID: 25203661
[TBL] [Abstract][Full Text] [Related]
13. The use of a "cheese-wire" suture in trabeculectomy.
Prem-Venkatesh ; Ramamurthi S; Montgomery DM
Br J Ophthalmol; 2007 Apr; 91(4):500-4. PubMed ID: 17372339
[TBL] [Abstract][Full Text] [Related]
14. Effects of tissue plasminogen activator on glaucoma filter blebs in rabbits.
Fourman S; Vaid K
Ophthalmic Surg; 1989 Sep; 20(9):663-7. PubMed ID: 2510106
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for developing avascular filtering bleb after fornix-based trabeculectomy with mitomycin C.
Hirooka K; Mizote M; Baba T; Takagishi M; Shiraga F
J Glaucoma; 2009; 18(4):301-4. PubMed ID: 19365195
[TBL] [Abstract][Full Text] [Related]
16. Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
Belyea DA; Dan JA; Lieberman MF; Stamper RL
J Glaucoma; 1997 Apr; 6(2):90-8. PubMed ID: 9098816
[TBL] [Abstract][Full Text] [Related]
17. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
Burnstein Y; Higginbotham EJ
J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
[No Abstract] [Full Text] [Related]
18. Evaluation of trabeculectomy blebs using 3-dimensional cornea and anterior segment optical coherence tomography.
Kawana K; Kiuchi T; Yasuno Y; Oshika T
Ophthalmology; 2009 May; 116(5):848-55. PubMed ID: 19268366
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.
Heiligenhaus A; Steinmetz B; Lapuente R; Krallmann P; Althaus C; Steinkamp WK; Dick B
Br J Ophthalmol; 1998 Jul; 82(7):810-5. PubMed ID: 9924378
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
